Kathleen Borthwick, SVP, Interim CFO at Passage BIO, Inc. (PASG), sold 10,672 shares at $0.91 ($10K) on 2024-01-02, disclosed to the SEC on 2024-01-03.
Open-market sale of $10k PASG by SVP, Interim CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PASG | SELL | 2024-02-13 | $1K | — | Filing → |